首页 | 本学科首页   官方微博 | 高级检索  
检索        

五味子乙素对转染多药耐药1基因的MCF-7细胞的多药耐药逆转作用
作者姓名:Li L  Wang T  Xu ZL  Yu Y  Chen W  Chen F
作者单位:1. 310009,杭州,浙江大学附属第二医院肿瘤研究所
2. 复旦大学医学院,上海市肿瘤研究所
3. 浙江省中医院
4. 浙江大学生命科学院
5. 华东师范大学生科院生物医学系
摘    要:目的 探讨五味子乙素(SchB)对转染多药耐药1基因(MDR1)的人乳腺癌细胞MCF-7的多药耐药逆转作用及相关机制。方法 将人MDR1基因导入MCF-7细胞,形成耐药细胞株MCF-7/MDR1;用该细胞株为模型评价SchB的体外逆转多药耐药作用,用MTT法进行化疗药物单独或与SchB联合作用时对耐药细胞的IC50比较,计算逆转倍数。结果 转染细胞MCF-7/MDR表现为P糖蛋白高表达,对阿霉素、长春新碱、紫杉醇、高三尖杉酯的抗药性均增加;SchB(25μmol/L)显著减少阿霉素、长春新碱、紫杉醇和高三尖杉酯对MCF-7/MDR细胞的IC50,逆转倍数达6.03-23.94倍;SchB(25μmol/L)使MCF-7/MDR细胞对若丹明123的胞内积聚增加约5倍。效果与维拉帕米10μmol/L浓度时相当;但SchB(25μmol/L)不影响MCF-7/MDR细胞的P-糖蛋白表达。结论 SchB能有效逆转转染MDR1的MCF-7细胞的多药耐药,其机制可能是抑制了P-糖蛋白的药物外排生物学活性。

关 键 词:五味子乙素  转染多药耐药1基因  MCF-7细胞  多药耐药  逆转作用  中药

Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene
Li L,Wang T,Xu ZL,Yu Y,Chen W,Chen F.Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene[J].National Medical Journal of China,2005,85(23):1633-1637.
Authors:Li Ling  Wang Tao  Xu Zhi-liang  Yu Ying  Chen Wei  Chen Fei
Institution:Cancer Institute, Second Affiliated Hospital of Zhejiang University, Hangzhou 310009, China.
Abstract:OBJECTIVE: To investigate the multidrug resistance (MDR) reversal activity of schisandrin B (SchB) in transfected human breast cancer cell line MCF-7/MDR1. METHODS: Human breast cancer cells of the line MCF-7 were cultured and transfected with mdr1 gene so as to establish a P-glycoprotein (P-gp) stable-expressing cell line MCF-7/MDR1. The expression of P-gp in the MCF-7/mdr1 cells was assayed by flow cytometry using fluorescent antibody. MCF-7 cells transfected with blank plasmid MCF-7/neo was used as controls. Adriamycin (ADR), verapamil (VER), pacilitaxel (taxol), and homoharringtonine (HHT) were added into the culture fluid of the MCF-7/mdr1 cells and MTT method was used to detect the IC(50) of these drugs. The culture fluid of the MCF-7/MDR1 cells was added with SchB of the concentrations of 2.5, 12.5, 25, and 50 micromol/L and then added with ADR1 cells, MTT method was used to calculate the reversal effect (RF) of SchB on the MDR phenotype of the MCF-7/mdr1 cells. MTT method was used to calculate the RF. Another culture fluid of MCF-7/mdr1 cells was added with 25 micromol/L SchB and then with ADR, vincristine (VCR), pacilitaxel, and HHT with that added with 10 micromol/L VER as control. After treatment with SchB the MF7/mgr1 cells were co-incubated with 5 micromol/L rhodamine (Rh)-123, then flow cytometry was used to detect the accumulation of Rh-123 within the cells. After treatment with 25 micromol/L SchB for 0, 0.5, 1, 6, 24, 48, and 72 hours flow cytometry was used to detect the P-gp expression in the MF7/mgr1 cells. RESULTS: The transfected MCF-7/MDR1 cells overexpressed P-gp and exhibited resistance to multiple drugs, including ADR, VCR, pacilitaxel and HHT. SchB (25 micromol/L) significantly enhanced the sensitivity of the MCF-7/MDR1 cells to above mentioned chemotherapeutic agents, with a reversal factors of 6.03 to 23.94 times. The effect of SchB (25 micromol/L) on Rh-123 accumulation in MDR cells was equivalent to that of 10 micromol/L VER, however no significant difference was found in the effect of SchB (25 micromol/L) on the P-gp expression in the MCF-7/MDR1 cells. CONCLUSION: SchB is able to restore the drug sensitivity in the transfected MCF7/MDR1 cells, with a possible mechanism of increasing the drug influx via inhibiting the P-gp function.
Keywords:Multidrug resistance  P-glycoprotein  Schisandrin B (SchB)  Reverse
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号